Photo: CNBC
Tata Healthcare Likely To Launch Moderna's COVID-19 Vaccine In India
Tata Medical and Diagnostics Ltd are likely to launch Moderna's COVID-19 vaccine in India as it has started exploratory talks with US’ Moderna Inc. To carry out the clinical trials, the Tata group's healthcare venture might collaborate with the Council of Scientific and Industrial Research. Varying from Pfizer’s vaccine, Moderna can be stored at normal fridge temperature, making it more favourable to be adopted by underdeveloped countries… read-more
Tags: Moderna, United States, Covid Vaccine, Cold Chain, Pfizer
Courtesy: The Indian Express
Photo: India Today
Bharat Biotech CMD Slams People Doubting Over 'Covaxin' Efficacy
Slamming reports criticizing Bharat Biotech's Covaxin, Chairman of the company Dr Krishna Ella stated the vaccine is nowhere inferior to Pfizer’s COVID-19 vaccine. In the press conference addressed by Dr Ella on January 4, he expressed his anger over people for "gossiping" and backlashing Indian companies. Speaking on transparency, he said that more than 70 articles had been published and Bharat Biotech conducted trials in over 12 countries… read-more
Tags: Bharat biotech, Covaxin, Coronavirus, Pfizer, Covid-19
Courtesy: Livemint
Photo: MediCircle
Serum Institute Of India Develops First Indigenous Pneumonia Vaccine
The Serum Institute of India has successfully developed the country's first indigenous vaccine against pneumonia. The domestic vaccine will reduce the dependency on earlier two vaccines by Pfizer and GlaxoSmithKline, both foreign drug-makers. After securing approval by the Indian drug regulator in July 2020, the SII has conducted the vaccine's trials in India and the Gambia of Africa. Reportedly, the vaccine will be available in the Indian… read-more
Tags: Serum Institute of India, pneumonia, vaccine, Indigenous, Pfizer
Courtesy: Zee News
Photo: Euronews
Confidence Over Pfizer's Efficacy Against UK COVID Strain: BioNTech
Amidst the fear of a new COVID-19 strain spreading in the UK, BioNTech CEO Ugur Sahin said that the company has "Scientific confidence" that Pfizer vaccine will work against the new variant as well. However, the efficacy can be confirmed only after studies, he added. Moreover, the company is ready to make changes in the vaccine to tackle the new strain of COVID-19, subject to the approval by the regulators.
Tags: World news, Pfizer, Coronavirus, BioNTech
Courtesy: The New Indian Express
Photo: ABC7 News
ICU Nurse Became First To Receive COVID-19 Vaccine in US
After the US gave emergency approval to Pfizer Covid-19 vaccine on December 11, an ICU nurse from New York 'Sandra Lindsay' became the first one to receive the Covid-19 vaccine in the U.S. After being inoculated at Long Island Medical Center in Queens, Lindsay said “I feel hopeful today, relieved. I feel like healing is coming". Later, American President Trump tweeted, “First Vaccine Administered. Congratulations USA! Congratulations WORLD… read-more
Tags: United States, Pfizer, Covid-19, Sandra Lindsay, Donald Trump
Courtesy: The Indian Express
Photo: The Financial Express
Pfizer Asks DCGI's Approval For Vaccine Distribution In India
As per reports, Drugs Controller General of India (DCGI) has received a request from the US-based Pfizer for Emergency Use Authorization of the COVID-19 vaccine. In its application, Pfizer has asked for permission to import, sell and distribute the vaccine immediately without clinical trials on Indian population under New Drugs and Clinical Trials Rules, 2019. Earlier… read-more
Tags: Pfizer, DCGI, India, Covid-19 Vaccine
Courtesy: Livemint
Photo: New York Post
Bahrain Becomes Second Country To Authorise Pfizer COVID-19 Vaccine
Bahrain has become the second country to approve the emergency use of Pfizer's COVID-19 vaccine after the UK. However, the country has not mentioned when the vaccination drive will start or how many doses it has ordered. The decision was taken amid Bahrain already giving nod to emergency use of Chinese vaccine developed by Sinopharm. It has also vaccinated about 6,000 people with the Sinopharm-made vaccine.
Tags: Bahrain, Pfizer, Coronavirus Vaccines, World news
Courtesy: The Indian Express
Photo: Interview Times
Obama, Bush, Clinton Ready To Vaccinate Publicly To Raise Awareness
To convince the people of COVID-19 vaccine's effectiveness, three former US Presidents - Barack Obama, George Bush and Bill Clinton - have decided to vaccinate in public. However, the trio expects US' top epidemiologist Dr Anthony Fauci's confirmation on the safety of a vaccine before inoculation. Reportedly, the US Food and Drug Administration will take a call on the vaccines in their meetings on December 10 and 17.
Tags: U.SA., President, food and drug administration, vaccine, Covid-19, Pfizer, Moderna
Courtesy: Hindustan Times
Photo: The Financial Express
Pfizer Open For Chances To Make COVID-19 Vaccine Available In India
The COVID-19 vaccine maker Pfizer has said it is open for ways through which the vaccine can be availed in India. The pharma giant had stated that they are in talks with several governments, including India, to supply vaccine in the country. However, Pfizer has stated that vaccines would be given based on contracts with the governments. Earlier, the UK had become the first country to approve Pfizer's Vaccine.
Tags: Covid-19 Vaccine, Pfizer, India, UK
Courtesy: Livemint
Photo: European Pharmaceutical Review
Indians Plan To Visit UK To Receive COVID-19 Vaccine Shot
Soon after UK approved use of Pfizer vaccine against COVID-19 on November 3, Indian travel agents have started to getting queries regarding the travel arrangements between both the countries. Interestingly, some travel agents have even launched packages to lure Indian travellers who are eyeing to go to UK to receive the vaccine shot. Reportedly, EaseMyTrip.com is planning to initiate 3-night travel package in this regard.
Tags: Covid-19, Pfizer, BioNTech, UK, India
Courtesy: Times of India